Eqis Capital Management, Inc. Dexcom Inc Transaction History

Eqis Capital Management, Inc.

$1.21 Billion
Q3 2024

A detailed history of Eqis Capital Management, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 3,035 shares of DXCM stock, worth $242,921. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,035

Previous 2,754 10.2%

Holding current value

$242,921

Previous $312,000 34.94%

% of portfolio

0.02%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $17,984 - $32,612	281 Added 10.2%	3,035 $203,000
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $32,982 - $41,994	299 Added 12.18%	2,754 $312,000
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $13,592 - $16,671	119 Added 5.09%	2,455 $340,000
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $67,261 - $110,626	-891 Reduced 27.61%	2,336 $289,000
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $134,511 - $215,584	1,563 Added 93.93%	3,227 $301,000
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $187,150 - $217,950	1,664 New	1,664 $213,000
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $243,725 - $327,023	-2,284 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $1,376 - $1,834	17 Added 0.75%	2,284 $975,000
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $9,072 - $11,207	-107 Reduced 4.51%	2,267 $815,000
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $9,906 - $13,271	-127 Reduced 5.08%	2,374 $878,000
Q3 2020 Nov 10, 2020	SELL	$95.51 - $112.95 $95 - $112	-1 Reduced 0.04%	2,501 $1.03 Million
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $5,139 - $8,637	82 Added 3.39%	2,502 $1.01 Million
Q1 2020 May 12, 2020	SELL	$47.79 - $75.63 $5,734 - $9,075	-120 Reduced 4.72%	2,420 $581,000
Q4 2019 Jan 24, 2020	SELL	$36.62 - $57.29 $20,910 - $32,712	-571 Reduced 18.35%	2,540 $556,000
Q3 2019 Nov 05, 2019	BUY	$35.53 - $43.8 $355 - $438	10 Added 0.32%	3,111 $464,000
Q2 2019 Jul 18, 2019	SELL	$27.84 - $38.92 $49,889 - $69,744	-1,792 Reduced 36.62%	3,101 $465,000
Q1 2019 Apr 18, 2019	SELL	$28.07 - $38.18 $229,724 - $312,465	-8,184 Reduced 62.58%	4,893 $583,000
Q4 2018 Jan 25, 2019	SELL	$26.99 - $37.37 $30,957 - $42,863	-1,147 Reduced 8.06%	13,077 $1.57 Million
Q3 2018 Oct 17, 2018	BUY	$23.35 - $36.72 $12,001 - $18,874	514 Added 3.75%	14,224 $2.08 Million
Q2 2018 Jul 27, 2018	BUY	$17.54 - $25.22 $4,121 - $5,926	235 Added 1.74%	13,710 $1.3 Million
Q1 2018 Apr 06, 2018	SELL	$13.06 - $18.54 $3,604 - $5,117	-276 Reduced 2.01%	13,475 $999,000
Q4 2017 Jan 25, 2018	BUY	$11.12 - $15.38 $22 - $30	2 Added 0.01%	13,751 $789,000
Q3 2017 Oct 03, 2017	BUY	$11.36 - $18.98 $156,188 - $260,956	13,749	13,749 $673,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account

Eqis Capital Management, Inc. Dexcom Inc Transaction History